The Efficacy and Safety of Sofadil for Injection in the Treatment of Acute Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 236 participants.
Also called NCT04453800
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 236 participants
- Registry
-
NCT04453800
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04453800. Randomized; double masking; primary purpose treatment. Start 2016-10-01 (actual); primary completion 2018-01-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety of Sofadil for Injection in the Treatment of Acute Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- sofadil【Neu2000KW】
- Intervention (Drug)
- Sofadil
- Intervention (Drug)
- Sofadil
- Intervention (Other)
- placebo
- Lead sponsor
- Peking University Third Hospital
Record details
- Record id
cardio:ct-nct04453800- Content hash
fa2f9edefc36ee77ab501ed68701e09411d1441f9f752cf6ed35772acb5784b7